Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
SynopsisH

Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia

Eric Wooltorton
CMAJ June 22, 2004 170 (13) 1908; DOI: https://doi.org/10.1503/cmaj.1040882
Eric Wooltorton
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 170 no. 13 1908
DOI 
https://doi.org/10.1503/cmaj.1040882
PubMed 
15210635
History 
  • Published online June 21, 2004.
Copyright & Usage 
© 2004 Canadian Medical Association or its licensors

Author Information

  1. Eric Wooltorton
  1. CMAJ

Statistics from Altmetric.com

Usage statistics: June 2004 to January 2023

AbstractFullPdf
Jun 20040426197
Jul 20040279210
Aug 2004715666
Sep 2004613961
Oct 2004814459
Nov 2004713269
Dec 200458634
Jan 2005614536
Feb 200558433
Mar 200558951
Apr 200519652
May 200537853
Jun 200547535
Jul 200526526
Aug 200534423
Sep 200523822
Oct 200536519
Nov 200504738
Dec 200523524
Jan 200901010
Feb 20090177
Mar 20090266
Apr 20090194
May 20090228
Jun 20090195
Jul 20090183
Aug 2009082
Sep 20090135
Oct 2009098
Nov 2009026
Dec 2009061
Jan 20100165
Feb 2010082
Mar 2010096
Apr 201001914
May 2010072
Jun 20100120
Jul 20100144
Aug 2010090
Sep 2010053
Oct 20100117
Nov 20100105
Dec 20100105
Jan 2011065
Feb 20110155
Mar 20110136
Apr 2011092
May 20110193
Jun 20110162
Jul 2011081
Aug 20110235
Sep 20110153
Oct 20110158
Nov 201102118
Dec 20110238
Jan 201201711
Feb 201201911
Mar 2012063
Apr 2012099
May 20120126
Jun 2012085
Jul 20120127
Aug 20120116
Sep 20120162
Oct 20120119
Nov 201201214
Dec 2012076
Jan 20130294
Feb 2013034
Mar 2013024
Apr 2013075
May 2013073
Jun 2013034
Jul 2013032
Aug 2013001
Sep 2013016
Oct 2013093
Nov 2013031
Dec 2013021
Jan 2014015
Feb 2014023
Mar 2014071
Apr 2014053
May 2014072
Jun 2014071
Jul 20140121
Aug 20140124
Sep 2014091
Oct 2014061
Nov 2014061
Dec 2014052
Jan 2015041
Feb 2015064
Mar 2015043
Apr 2015051
May 2015021
Jun 2015041
Jul 2015072
Aug 20150152
Sep 20150102
Oct 20150114
Nov 20150141
Dec 20150332
Jan 20160219
Feb 20160133
Mar 201601210
Apr 20160813
May 2016059
Jun 2016062
Jul 20160203
Aug 20160153
Sep 20160124
Oct 20160144
Nov 20160173
Dec 20160151
Jan 20170184
Feb 20170151
Mar 20170141
Apr 20170151
May 2017090
Jun 20170151
Jul 20170110
Aug 2017070
Sep 20170111
Oct 20170183
Nov 20170101
Dec 20170171
Jan 20180130
Feb 20180243
Mar 20180130
Apr 20180242
May 20180270
Jun 20180272
Jul 20180141
Aug 2018090
Sep 20180160
Oct 20180151
Nov 20180165
Dec 20180265
Jan 20190141
Feb 20190112
Mar 20190176
Apr 20190101
May 20190163
Jun 20190111
Jul 2019093
Aug 20190143
Sep 20190166
Oct 20190131
Nov 20190182
Dec 20190347
Jan 20200122
Feb 20200143
Mar 20200312
Apr 20200171
May 20200171
Jun 20200202
Jul 20200122
Aug 20200203
Sep 20200256
Oct 20200232
Nov 20200124
Dec 20200183
Jan 2021093
Feb 2021094
Mar 20210281
Apr 20210123
May 2021072
Jun 202101812
Jul 2021055
Aug 20210127
Sep 20210111
Oct 202101822
Nov 202101114
Dec 20210126
Jan 20220134
Feb 20220145
Mar 20220223
Apr 20220233
May 202201012
Jun 20220167
Jul 202202010
Aug 20220122
Sep 20220126
Oct 202201518
Nov 20220184
Dec 20220120
Jan 20230275

Cited By...

  • 8 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 170 (13)
CMAJ
Vol. 170, Issue 13
22 Jun 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia
Eric Wooltorton
CMAJ Jun 2004, 170 (13) 1908; DOI: 10.1503/cmaj.1040882

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia
Eric Wooltorton
CMAJ Jun 2004, 170 (13) 1908; DOI: 10.1503/cmaj.1040882
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Does β-blocker prophylaxis improve survival after major noncardiac surgery?
  • The changing ecology of avian flu
  • Applying the 2005 Canadian Hypertension Education Program recommendations: 4. Managing uncomplicated hypertension
Show more Synopsis

Similar Articles

Collections

  • Topics
    • Drugs: adverse reactions
    • Gastroenterology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire